If you've been tracking your cycle and something feels off — periods that show up when they feel like it, ovulation tests that never seem to peak, or months of trying to conceive without success — anovulation might be worth understanding properly.

Not in the panic-inducing way the internet tends to explain it. In the "let's actually understand what's happening in your body" way.

Anovulation simply means a cycle where your ovaries don't release an egg. And while that sounds straightforward, it's one of those topics that gets tangled in fear-based content and medical jargon fast. So let's slow down and go through it clearly — what it is, why it happens, how it's diagnosed, and what you can actually do about it.

Anovulation is a menstrual cycle in which no egg is released from the ovaries. It can happen occasionally in any woman, or chronically as part of an underlying hormonal condition.

Here's what surprises a lot of women: you can still have a period — or something that looks like one — without ovulating. That bleeding is called an anovulatory bleed, and it's caused by oestrogen building up and shedding the uterine lining. It can look almost identical to a regular period, which is why anovulation often goes unnoticed for years.

The absence of ovulation also means the absence of progesterone. Because progesterone is only produced after an egg is released, a cycle without ovulation is a cycle without that crucial second-phase hormone. Over time, that has real implications — not just for fertility, but for mood, sleep, bone health, and cycle regularity.

You're not imagining it. If something feels off, there's often a physiological reason behind it.

Anovulation affects approximately 1 in 10 women and is responsible for 21–30% of female infertility cases, making it one of the most common and treatable causes of difficulty conceiving.

NICE (National Institute for Health and Care Excellence) estimates that anovulation accounts for around 21% of infertility cases in the UK [NICE — Infertility: Background Information]. In the US, the National Institutes of Health puts that figure closer to 30% of female factor infertility [NIH].

An occasional anovulatory cycle is considered normal — particularly during puberty, perimenopause, or at times of significant stress. Chronic anovulation, where cycles repeatedly fail to result in ovulation, is a different picture and worth investigating with a doctor.

The most common signs of anovulation include irregular or absent periods, no detectable LH surge on ovulation tests, absent cervical mucus changes, and — in longer-term cases — difficulty conceiving.

Because anovulatory cycles can mimic regular periods, spotting the signs takes a bit of cycle literacy. Here's what to look for:

• Irregular cycles — periods arriving earlier or later than expected, or skipping entirely
• No ovulation test peak — LH surges that never appear, or that seem to rise and fall without a clear peak
• Absent cervical mucus changes — no egg-white consistency discharge around mid-cycle
• No mid-cycle cramping — some women notice Mittelschmerz (ovulation pain); its absence is worth noting
• PMS symptoms throughout the cycle — without the progesterone rise from ovulation, the hormonal rhythm feels flat or erratic
• Difficulty conceiving — particularly relevant for women who've been trying consistently
• Persistent fatigue or mood disruption — progesterone has calming, stabilising effects; when it's absent, the body often notices

None of these symptoms in isolation confirms anovulation. But a pattern across multiple cycles is worth discussing with a GP or specialist.

Anovulation is most commonly caused by hormonal disruption — including PCOS, thyroid dysfunction, elevated prolactin, pituitary dysfunction, significant weight changes, and chronic stress.

Let's go through the main drivers.

PCOS is the leading cause of chronic anovulation. It affects approximately 1 in 10 women of childbearing age worldwide, and irregular or absent ovulation is one of its defining features [Rotterdam Consensus Criteria, 2003].

In PCOS, elevated insulin — often driven by insulin resistance — signals the ovaries to produce excess androgens (including testosterone). This disrupts the hormonal cascade needed for follicle development and egg release. The follicles begin to grow but don't reach full maturity. They remain as small cysts on the ovaries, and ovulation doesn't happen.

This is why insulin sensitivity is so central to managing PCOS. When insulin is better regulated, androgens often come down, and ovulation can resume — or at least become more consistent.

Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) can disrupt ovulation. Thyroid hormones influence virtually every system in the body, including the reproductive axis. Low thyroid function in particular is associated with elevated prolactin, which suppresses the hormones needed for ovulation [Krassas et al., 2010].

Thyroid-related anovulation is often missed because thyroid symptoms can be subtle and TSH testing is sometimes done in isolation — without T3, T4, or thyroid antibodies. It's worth asking for a full panel if you suspect thyroid involvement.

Prolactin is the hormone best known for stimulating breast milk production. In higher-than-normal levels outside of pregnancy and breastfeeding, it suppresses LH and FSH — the two hormones your pituitary gland sends to the ovaries to trigger follicle development and ovulation.

Causes of elevated prolactin include pituitary adenomas (small benign tumours), certain medications (antidepressants, antipsychotics, some blood pressure drugs), and thyroid dysfunction [Melmed et al., 2011]. It's diagnosed with a blood test and is often very treatable.

The hypothalamus sends GnRH (gonadotropin-releasing hormone) to the pituitary, which then releases FSH and LH. If this signal chain is disrupted — by low body weight, over-exercising, chronic stress, or conditions like Sheehan's syndrome — the pituitary doesn't release enough FSH and LH, and ovulation doesn't occur.

This is sometimes called hypothalamic amenorrhoea, and it's particularly common in athletes, women who have experienced significant caloric restriction, and women under sustained high stress.

Both underweight and significant overweight can disrupt ovulation.

At very low body fat, the body perceives conditions as unsuitable for reproduction and downregulates the hormonal signals that trigger ovulation. In women with higher body weight, excess adipose tissue converts androgens to oestrogen, creating an oestrogen excess that can disrupt the hormonal cycle and interfere with ovulation [Pasquali et al., 2003].

This isn't about a number on the scale — it's about the body's hormonal environment. And it's why weight-related anovulation responds well to gradual, sustainable changes rather than crash approaches.

Some medications can suppress or interfere with ovulation — including long-term use of hormonal contraceptives (by design), corticosteroids, some antidepressants, antipsychotics, and chemotherapy agents. If you've recently come off hormonal contraception and your cycle is irregular, your body may still be recalibrating. This is very common, particularly after the pill, and doesn't always indicate a problem — though it does warrant monitoring.

Anovulation is diagnosed through a combination of cycle history, mid-luteal progesterone blood tests, hormone panels (LH, FSH, prolactin, TSH, AMH), and pelvic ultrasound to assess follicular development.

If your doctor suspects anovulation, here's what the diagnostic process typically looks like:

1. Cycle history review Your doctor will ask about the length and regularity of your cycles, any changes in bleeding, and symptoms at different points in the month. This is more informative than most people expect — a detailed cycle history can point clearly toward likely causes.

2. Mid-luteal progesterone blood test This is often the first-line test for confirming ovulation. Progesterone is measured around day 21 of a 28-day cycle (or 7 days before expected period in longer cycles). A level above 16–30 nmol/L suggests ovulation occurred [NICE Clinical Guideline CG156]. A low or absent progesterone rise suggests it didn't.

3. Hormone panel Depending on your symptoms, your doctor may test:

• FSH and LH (to assess pituitary function and identify PCOS-related patterns)
• Prolactin (to rule out hyperprolactinaemia)
• TSH, free T3, and T4 (thyroid function)
• AMH (anti-Müllerian hormone, to assess ovarian reserve)
• Fasting insulin and glucose (particularly relevant if PCOS is suspected)

4. Pelvic ultrasound A transvaginal or abdominal ultrasound can visualise the ovaries and assess follicle development. In PCOS, the ovaries may show a characteristic "string of pearls" appearance — multiple small follicles that haven't fully developed. An ultrasound can also check the uterine lining thickness and rule out other structural causes.

5. Endometrial biopsy (in some cases) Occasionally, a biopsy of the uterine lining may be performed to assess its health and thickness — particularly if the cycle history suggests prolonged oestrogen exposure without progesterone opposition.

The research on this is actually pretty clear: early investigation leads to earlier intervention and better outcomes. Don't wait for months of unexplained irregularity before asking for a referral.

Yes — anovulation is one of the most treatable causes of infertility. Treatment depends on the underlying cause and may include lifestyle changes, nutritional support, hormone-regulating supplements, or fertility medications.

The right approach depends entirely on what's driving the anovulation. There isn't one universal protocol, which is why diagnosis matters so much.

If anovulation is driven by PCOS and insulin resistance, improving insulin sensitivity is often the most effective first step. This typically involves changes to diet composition (particularly carbohydrate quality and protein intake), resistance training, stress management, and — for many women — targeted supplementation.

If it's thyroid-related, thyroid treatment (usually medication) often restores the hormonal environment for ovulation relatively quickly.

If it's prolactin-related, dopamine agonist medications like cabergoline can normalise prolactin levels with good success rates.

If it's hypothalamic (linked to low weight, over-exercise, or high stress), gradually restoring energy availability and reducing physiological stress is the primary intervention. This takes time, but the body's reproductive system is responsive when conditions improve.

For women with PCOS-related anovulation, the evidence for nutritional intervention is meaningful. Reducing refined carbohydrate load, prioritising protein at meals, and supporting blood sugar stability throughout the day has been shown to improve insulin sensitivity and reduce androgen levels — both of which support ovulation [Marsh & Brand-Miller, 2005].

Strength training has a particularly well-documented effect on insulin sensitivity in PCOS, with studies showing improvements in ovulatory frequency alongside metabolic markers [Harrison et al., 2011].

Sleep quality and stress load also matter more than most women are told. Cortisol directly suppresses GnRH pulsatility — the signal chain that initiates the hormonal cascade leading to ovulation. Chronic stress isn't a soft lifestyle issue; it's a physiological disruption.

For women with PCOS-related anovulation, myo-inositol is one of the most researched nutritional interventions available. It's a naturally occurring compound involved in insulin signalling — and women with PCOS often have reduced inositol availability in ovarian follicles [Unfer et al., 2017].

Clinical trials have shown that myo-inositol supplementation can improve insulin sensitivity, reduce androgens, and — importantly — support the restoration of ovulatory cycles. A meta-analysis of randomised controlled trials found that myo-inositol significantly improved ovulation rates in women with PCOS compared to placebo [Unfer et al., 2017].

Myoplus is MyOva's award-winning formulation built around this research. It combines myo-inositol with chromium (which supports healthy blood sugar regulation), folate in its active bioavailable form (L-5-methyltetrahydrofolate), and vitamin B6 — nutrients that work together to support hormonal balance and cycle regularity. It's not a magic fix. But it gives your body what it's often missing.

You can read more about Myoplus here.

When lifestyle and nutritional support aren't sufficient — or when there's time pressure around fertility — ovulation induction medications may be recommended:

Clomiphene citrate (Clomid®): A selective oestrogen receptor modulator that stimulates FSH and LH release. Studies show it triggers ovulation in up to 80% of women with anovulation [RCOG, 2014], though not all cycles result in pregnancy.

Letrozole: An aromatase inhibitor increasingly preferred over clomiphene for PCOS-related anovulation, with evidence suggesting higher live birth rates [Legro et al., 2014].

Both medications are typically short-term and used under medical supervision with cycle monitoring.

For women with chronic anovulation who haven't responded to other interventions, IVF can bypass the ovulation problem altogether by stimulating egg retrieval directly. It's not usually the first line of treatment, but it's an important option for those who've exhausted or aren't suitable for other approaches.

Without ovulation, natural conception isn't possible — but anovulation is one of the most treatable causes of infertility, and many women restore regular ovulation with targeted intervention.

This is one of the most important things to understand about anovulation: it's a symptom, not a verdict.

Many women who receive an anovulation diagnosis — whether through PCOS, thyroid issues, or lifestyle factors — go on to ovulate regularly and conceive, either naturally or with support. The prognosis depends on the cause, but the overall picture for anovulatory infertility is significantly more optimistic than for many other fertility challenges.

Your diagnosis is a starting point, not a full stop.

Early investigation means earlier intervention. And earlier intervention means more options. If you've been tracking your cycle and something doesn't add up, that instinct is worth acting on.

Many women don't notice anything different — which is what makes anovulation easy to miss. Some women notice that their ovulation test never shows a clear peak, that their cycle feels "flat" without the typical mid-cycle signs like cervical mucus changes, or that their periods feel different (lighter, heavier, or more irregular). If you're tracking your cycle closely, absent signs of ovulation across multiple cycles is worth raising with a doctor.

Yes. Chronic stress elevates cortisol, which suppresses the GnRH signal from the hypothalamus. This disrupts the hormonal cascade that leads to ovulation. Stress-related anovulation is particularly common in women who are under prolonged work or personal pressure, in athletes with high training loads, or in women going through significant life upheaval. Addressing the physiological stress load — not just the perceived stress — is often part of recovery.

The pill works by suppressing ovulation. After stopping, it can take time for your natural cycle to resume — anywhere from a few weeks to several months. This isn't technically anovulation; it's post-pill cycle recalibration. However, if cycles remain irregular beyond three to six months, particularly if you had hormonal symptoms before starting the pill, it's worth investigating whether an underlying condition like PCOS is present.

This depends entirely on the cause. For hypothalamic anovulation linked to low weight or excessive exercise, restoration of adequate energy availability can lead to ovulatory cycles returning within a few months. For PCOS-related anovulation, improving insulin sensitivity through lifestyle and supplementation typically takes three to six months to show meaningful change in cycle regularity. Hormone-related causes (thyroid, prolactin) may respond more quickly once medically addressed.

No, but PCOS is one of the most common causes of anovulation. Anovulation simply means a cycle without ovulation, and it can arise from multiple different causes. Not all women with anovulation have PCOS, and not all women with PCOS have complete anovulation — some ovulate sporadically. Diagnosis requires investigation to identify the specific driver.

Understanding your cycle — including what ovulation actually looks like, and what it looks like when it's absent — is one of the most useful things you can do for your health. Not because fertility is the only measure that matters, but because ovulation is a genuine health marker.

Regular ovulation means your body is producing progesterone. It means your hormonal rhythm is functioning. It means your reproductive axis is communicating properly.

When that's not happening, your body is trying to tell you something. The good news is that in most cases, there's something meaningful you can do about it.

If any of this resonates with your experience, take it to a GP, ask for the relevant tests, and start building a clearer picture. You don't have to piece this together alone.

• What Is PCOS?
• Insulin Resistance and PCOS: What It Is and Why It Matters
• Myo-Inositol for PCOS: What the Research Actually Says
• PCOS and Fertility: What to Know Before You Start Trying

1. National Institute for Health and Care Excellence (NICE). Infertility: Background Information — Causes. Available at: https://cks.nice.org.uk/topics/infertility/background-information/causes/

2. National Institutes of Health (NIH). Female Infertility. U.S. Department of Health and Human Services.

3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction, 19(1), 41–47.

4. Krassas GE, Poppe K, Glinoer D. (2010). Thyroid Function and Human Reproductive Health. Endocrine Reviews, 31(5), 702–755.

5. Melmed S, Casanueva FF, Hoffman AR, et al. (2011). Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 96(2), 273–288.

6. Pasquali R, Gambineri A, Pagotto U. (2006). The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG: An International Journal of Obstetrics and Gynaecology, 113(10), 1148–1159.

7. Marsh K, Brand-Miller J. (2005). The optimal diet for women with polycystic ovary syndrome? British Journal of Nutrition, 94(2), 154–165.

8. Harrison CL, Lombard CB, Moran LJ, Teede HJ. (2011). Exercise therapy in polycystic ovary syndrome: a systematic review. Human Reproduction Update, 17(2), 171–183.

9. Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. (2017). Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocrine Connections, 6(8), 647–658.

10. Royal College of Obstetricians and Gynaecologists (RCOG). (2014). Ovulation Induction. Green-top Guideline No. 12.

11. Legro RS, Brzyski RG, Diamond MP, et al. (2014). Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome. New England Journal of Medicine, 371(2), 119–129.

12. NICE Clinical Guideline CG156. (2013). Fertility Problems: Assessment and Treatment.